173 related articles for article (PubMed ID: 18702646)
21. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis.
Férec C; Raguénès O; Salomon R; Roche C; Bernard JP; Guillot M; Quéré I; Faure C; Mercier B; Audrézet MP; Guillausseau PJ; Dupont C; Munnich A; Bignon JD; Le Bodic L
J Med Genet; 1999 Mar; 36(3):228-32. PubMed ID: 10204851
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis of hereditary pancreatitis.
Chen JM; Ferec C
Eur J Hum Genet; 2000 Jul; 8(7):473-9. PubMed ID: 10909845
[TBL] [Abstract][Full Text] [Related]
23. Hereditary chronic pancreatitis.
Teich N; Mössner J
Best Pract Res Clin Gastroenterol; 2008; 22(1):115-30. PubMed ID: 18206817
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel pancreatitis-associated missense mutation, R116C, in the human cationic trypsinogen gene (PRSS1).
Le Maréchal C; Bretagne JF; Raguénès O; Quéré I; Chen JM; Ferec C
Mol Genet Metab; 2001 Nov; 74(3):342-4. PubMed ID: 11708864
[TBL] [Abstract][Full Text] [Related]
25. Childhood-onset hereditary pancreatitis with mutations in the CT gene and SPINK1 gene.
Awano H; Lee T; Yagi M; Masamune A; Kume K; Takeshima Y; Iijima K
Pediatr Int; 2013 Oct; 55(5):646-9. PubMed ID: 24134754
[TBL] [Abstract][Full Text] [Related]
26. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis.
Keiles S; Kammesheidt A
Pancreas; 2006 Oct; 33(3):221-7. PubMed ID: 17003641
[TBL] [Abstract][Full Text] [Related]
27. Hereditary pancreatitis and secondary screening for early pancreatic cancer.
Vitone LJ; Greenhalf W; Howes NR; Neoptolemos JP
Rocz Akad Med Bialymst; 2005; 50():73-84. PubMed ID: 16358943
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity in hereditary pancreatitis.
Dasouki MJ; Cogan J; Summar ML; Neblitt W; Foroud T; Koller D; Phillips JA
Am J Med Genet; 1998 Apr; 77(1):47-53. PubMed ID: 9557894
[TBL] [Abstract][Full Text] [Related]
29. Trypsinogen mutations in pancreatic disorders.
Vitone LJ; Greenhalf W; Howes NR; Raraty MG; Neoptolemos JP
Endocrinol Metab Clin North Am; 2006 Jun; 35(2):271-87, viii. PubMed ID: 16632092
[TBL] [Abstract][Full Text] [Related]
30. Mortality rate and risk factors in patients with hereditary pancreatitis: uni- and multidimensional analyses.
Rebours V; Boutron-Ruault MC; Jooste V; Bouvier AM; Hammel P; Ruszniewski P; Lévy P
Am J Gastroenterol; 2009 Sep; 104(9):2312-7. PubMed ID: 19550412
[TBL] [Abstract][Full Text] [Related]
31. Identification of a hereditary pancreatitis mutation in four West Virginia families.
Elitsur Y; Chertow BC; Jewell RD; Finver SN; Primerano DA
Pediatr Res; 1998 Dec; 44(6):927-30. PubMed ID: 9853929
[TBL] [Abstract][Full Text] [Related]
32. Histopathological features of patients with chronic pancreatitis due to mutations in the PRSS1 gene: evaluation of BRAF and KRAS2 mutations.
Felderbauer P; Stricker I; Schnekenburger J; Bulut K; Chromik AM; Belyaev O; Muller CA; Uhl W; Tannapfel A; Schmidt WE
Digestion; 2008; 78(1):60-5. PubMed ID: 18946221
[TBL] [Abstract][Full Text] [Related]
33. Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis.
Chen JM; Piepoli Bis A; Le Bodic L; Ruszniewski P; Robaszkiewicz M; Deprez PH; Raguenes O; Quere I; Andriulli A; Ferec C
Clin Genet; 2001 Mar; 59(3):189-93. PubMed ID: 11260229
[TBL] [Abstract][Full Text] [Related]
34. Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series.
Rebours V; Boutron-Ruault MC; Schnee M; Férec C; Maire F; Hammel P; Ruszniewski P; Lévy P
Am J Gastroenterol; 2008 Jan; 103(1):111-9. PubMed ID: 18184119
[TBL] [Abstract][Full Text] [Related]
35. Keratin 8 mutations are not associated with familial, sporadic and alcoholic pancreatitis in a population from the United States.
Schneider A; Lamb J; Barmada MM; Cuneo A; Money ME; Whitcomb DC
Pancreatology; 2006; 6(1-2):103-8. PubMed ID: 16327287
[TBL] [Abstract][Full Text] [Related]
36. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.
Felderbauer P; Karakas E; Fendrich V; Bulut K; Horn T; Lebert R; Holland-Letz T; Schmitz F; Bartsch D; Schmidt WE
Am J Gastroenterol; 2008 Feb; 103(2):368-74. PubMed ID: 18076731
[TBL] [Abstract][Full Text] [Related]
37. Gene conversion between cationic trypsinogen (PRSS1) and the pseudogene trypsinogen 6 (PRSS3P2) in patients with chronic pancreatitis.
Rygiel AM; Beer S; Simon P; Wertheim-Tysarowska K; Oracz G; Kucharzik T; Tysarowski A; Niepokój K; Kierkus J; Jurek M; Gawliński P; Poznański J; Bal J; Lerch MM; Sahin-Tóth M; Weiss FU
Hum Mutat; 2015 Mar; 36(3):350-6. PubMed ID: 25546417
[TBL] [Abstract][Full Text] [Related]
38. Characterisation of a transgenic mouse expressing R122H human cationic trypsinogen.
Selig L; Sack U; Gaiser S; Klöppel G; Savkovic V; Mössner J; Keim V; Bödeker H
BMC Gastroenterol; 2006 Oct; 6():30. PubMed ID: 17069643
[TBL] [Abstract][Full Text] [Related]
39. Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.
Teich N; Rosendahl J; Tóth M; Mössner J; Sahin-Tóth M
Hum Mutat; 2006 Aug; 27(8):721-30. PubMed ID: 16791840
[TBL] [Abstract][Full Text] [Related]
40. SPINK1 and PRSS1 mutations in benign pancreatic hyperenzymemia.
Gullo L; Laghi L; Migliori M; Lucrezio L; Bianchi P; Randolph AE; Mantovani V; Bastagli L; Pezzilli R; Malesci A
Pancreas; 2008 Jul; 37(1):31-5. PubMed ID: 18580441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
